Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-25-011169
Filing Date
2025-03-31
Accepted
2025-03-31 07:50:37
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ef20039001_10k.htm   iXBRL 10-K 2216782
2 EXHIBIT 10.21 ef20039001_ex10-21.htm EX-10.21 101684
3 EXHIBIT 19 ef20039001_ex19.htm EX-19 80001
4 EXHIBIT 21.1 ef20039001_ex21-1.htm EX-21.1 3237
5 EXHIBIT 23.1 ef20039001_ex23-1.htm EX-23.1 3030
6 EXHIBIT 31.1 ef20039001_ex31-1.htm EX-31.1 12454
7 EXHIBIT 31.2 ef20039001_ex31-2.htm EX-31.2 12476
8 EXHIBIT 32.1 ef20039001_ex32-1.htm EX-32.1 5140
9 EXHIBIT 32.2 ef20039001_ex32-2.htm EX-32.2 5147
  Complete submission text file 0001140361-25-011169.txt   10577837

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA galt-20241231.xsd EX-101.SCH 83333
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20241231_cal.xml EX-101.CAL 44681
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20241231_def.xml EX-101.DEF 423018
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20241231_lab.xml EX-101.LAB 1011827
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20241231_pre.xml EX-101.PRE 637020
95 EXTRACTED XBRL INSTANCE DOCUMENT ef20039001_10k_htm.xml XML 1449634
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 25788957
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)